Trials / Completed
CompletedNCT01113606
A Trial of Skin Care Protocols for Facial Resurfacing
A Double-Blind, Randomized, Controlled Trial to Assess the Effects of the Obagi Nu-Derm System on Re-Epithelialization After Chemical Peel or Ablative Laser Resurfacing.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- The Plastic Surgery Foundation · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- —
Summary
The aims of the Skin Product Assessment Research study were to (1) develop an infrastructure and process for industry-sponsored, Plastic Surgery Educational Foundation (PSEF) research in facial aesthetic surgery and (2) test the research process by comparing outcomes of the Obagi Nu-Derm System (ODNS) and conventional therapy as treatment adjuncts in ablative facial resurfacing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Obagi New-Derm System | |
| OTHER | Standard of Care |
Timeline
- First posted
- 2010-04-30
- Last updated
- 2010-04-30
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01113606. Inclusion in this directory is not an endorsement.